MiR-203 inhibits proliferation of HCC cells by targeting survivin

Cell Biochemistry and Function

Volumn 31, Issue 1, 2013, Pages 82-85

  Wei, Wang ^a   Wanjun, Liu ^b   Hui, Sun ^a   Dongyue, Chen ^c   Xinjun, Yao ^d   Jisheng, Zhao ^a  

^a JILIN UNIVERSITY   (China)

^b Siping Centre People's Hospital   (China)

^c Changchun Children's Hospital   (China)

^d Qingyuan People's Hospital   (China)

Author keywords

Hepatocellular carcinoma microRNA 203; Survivin

Indexed keywords

ANTIMITOTIC AGENT; MICRORNA; MICRORNA 203; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84872396155     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2863     Document Type: Article

References (20)

1. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening[J]. Semin Liver Dis 2005; 25(2): 143-154.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin 2005; 55(2): 74-108.
3. Hobert O. Gene regulation by transcription factors and microRNAs[J]. Science 2008; 319(5871): 1785-1786.
4. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer[J]. Nat Rev Cancer 2006; 6(4): 259-269.
5. Viticchie G, Lena AM, Latina A, et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines[J]. Cell Cycle 2011; 10(7): 1121-1131.
6. Bueno MJ, Perez de Castro I, Gomez de Cedron M, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression[J]. Cancer Cell, 2008, 13(6):496-506.
7. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. Jama 2008; 299(4): 425-436.
8. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, et al. miR-203 represses 'stemness' by repressing DeltaNp63[J]. Cell Death Differ, 2008, 15(7):1187-1195.
9. Chen HY, Han ZB, Fan JW, et al. miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver[J]. Med Oncol, 2011.
10. Furuta M, Kozaki KI, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma[J]. Carcinogenesis, 31(5):766-776.
11. Mamori S, Matsushima M, Matsuura T, et al. Survivin is expressed in early hepatocellular carcinoma and surrounding hepatitis tissue[J]. Mol Med Report 2009; 2(6): 911-915.
12. Yang Y, Zhu J, Gou H, et al. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC)[J]. Med Oncol 2011; 28(3): 796-803.
13. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method[J]. Nat Protoc 2008; 3(6): 1101-1108.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods 2001; 25(4): 402-408.
15. Gagarina V, Carlberg AL, Pereira-Mouries L, et al. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins[J]. J Biol Chem 2008; 283(1): 648-659.
16. Pavlyukov MS, Antipova NV, Balashova MV, et al. Survivin monomer plays an essential role in apoptosis regulation[J]. J Biol Chem 2011; 286(26): 23296-23307.
17. Nestal de Moraes G, Silva KL, Vasconcelos FC, et al. Survivin overexpression correlates with an apoptosis-resistant phenotype in chronic myeloid leukemia cells[J]. Oncol Rep, 2011, 25(6):1613-1619.
18. Lens SM, Rodriguez JA, Vader G, et al. Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres[J]. Mol Biol Cell 2006; 17(4): 1897-1909.
19. Nousiainen M, Sillje HH, Sauer G, et al. Phosphoproteome analysis of the human mitotic spindle[J]. Proc Natl Acad Sci U S A 2006; 103(14): 5391-5396.
20. Chen J, Yang B, Zhang S, et al. Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma[J]. Cancer Gene Ther 2012; 19(5): 328-335.